All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Not reported | 2021-003760-27 | INCENTIVE-QIV-3-EU: Immunogenicity, molecular profiling of a marketed quadrivalent influenza vaccine (Vaxigrip Tetra®) administered by the intramuscular route in participants aged 6 to 8 months | 2023-09-12 | due-trials |
Reported results | 2020-000824-21 | An open label phase II study to evaluate neratinib for treatment and prevention of subsequent CNS event(s) in patients with brain metastasis of advanced HER2 positive breast cancer | 2021-11-24 | due-trials |
Not reported Terminated | 2018-001295-37 | CILOSTAZOL AS IMATINIB SYNERGISER IN PATIENTS WITH UNRESECTABLE OR METASTATIC GIST TREATED BY GLIVEC® | 2021-02-10 | due-trials |
Reported results Terminated | 2016-004398-41 | Multicentre, non-randomised, open-label, single agent phase II study to determine the clinical benefit of trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer patients with brain me... | 2018-08-27 | due-trials |
Reported results | 2016-000879-24 | Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined with Endocrine Therapy in Estrogen Receptor Positive/ HER2 Negative Breast CAncer | 2023-02-01 | due-trials |
Not reported | 2015-004618-10 | Study of the inter-individual variation of PhArmaCo-kinetics of InFliximab during treatment Induction in patients with Crohn’s disease and Ulcerative Colitis | 2023-08-16 | due-trials |
Reported results | 2013-004607-39 | Safety of preoperative administration of hemin to reduce the risk of acute kidney injury after on-pump cardiac surgery: a pilot randomised study in double blind. | 2017-07-25 | due-trials |
Reported results | 2012-005655-16 | Regorafenib Assessment in Refractory advanced Colorectal cancer | 2018-01-26 | due-trials |
Not reported | 2012-005626-30 | Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced (non resectable) and metastatic cholangiocarcinoma: a randomized double-blinded phase II trial. Evalua... | 2020-12-03 | due-trials |
Reported results | 2012-004860-22 | The [PEARL] Study : Pet imaging as a biomarker of Everolimus Added value in hormone Refractory postmenopausaL women | 2021-07-05 | due-trials |
Reported results | 2012-003666-41 | The LuMEn study 177Lu-octreotate treatment outcome prediction using Multimodality imaging in refractory neuroEndocrine tumours | 2022-09-16 | due-trials |
Not reported | 2012-003592-19 | Evaluation of tumoral perfusion modification by dynamic imaging after chemotherapy combining gemcitabine and nab-paclitaxel (Abraxane) in patients with potentially operable, locally advanced or metast... | 2017-04-30 | due-trials |
Not reported | 2012-003516-31 | Evaluation of tumoral perfusion modification by dynamic imaging after neoadjuvant chemotherapy combining gemcitabine and a Hedgehog inhibitor (Vismodegib) in patients with resectable pancreatic adenoc... | 2016-05-03 | due-trials |
Reported results | 2011-006280-21 | Correlating the tumoral metabolic progression index measured by serial FDG PET-CT and apparent diffusion coefficient measured by MRI to patient's outcome in advance colorectal cancer | 2021-09-25 | due-trials |
Not reported | 2011-006224-21 | A pre-operative window study evaluating Denosumab, a RANK-Ligand (RANKL) inhibitor and its biological effects in young pre-menopausal women diagnosed with early breast cancer | 2017-01-06 | due-trials |
Reported results | 2011-004239-29 | what are the optimal doses of broad spectrum B-lactams to administer to obese patients if infected? | 2012-09-28 | due-trials |
Reported results | 2011-004070-29 | What are the optimal doses of cephalosporins of first and second generation to manage obese patients? Quelles sont les doses optimales de céphalosporines de premières et deuxième génération à admin... | 2013-07-12 | due-trials |
Reported results | 2009-017350-13 | Pharmacokinetics of oseltamivir in patients with infection due to influenza A H1N1 2009 admitted in intensive care unit. | 2013-07-15 | due-trials |
Reported results | 2009-014346-28 | Timing of intubation in a modified rapid sequence induction with remifentanil | 2009-12-31 | due-trials |
Not reported | 2009-009467-59 | Feasibility study of hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with stage III or only pleural stage IV ovarian carcinoma in first line therapy. | 2015-09-27 | due-trials |
Reported results | 2008-007712-14 | Monitoring of serum concentrations of posaconazole given as prophylaxis or therapy. | 2010-08-31 | due-trials |
Reported results | 2008-004278-41 | A phase II study of doxorubicin, cyclophosphamide and vindesine with valproic acid in patients with refractory or relapsing small cell lung cancer after platinum derivatives and etoposide. | 2013-11-29 | due-trials |
Reported results | 2007-001174-81 | RANDOMIZED MULTICENTER PHASE III STUDY IN PATIENTS WITH LOCALLY ADVANCED ADENOCARCINOMA OF THE PANCREAS: GEMCITABINE WITH OR WITHOUT CHEMORADIOTHERAPY AND WITH OR WITHOUT ERLOTINIB | 2014-01-31 | due-trials |
Reported results | 2006-006944-78 | Evaluation du bénéfice de survie lors de l'adjonction de pentoxifylline à la corticothérapie dans l'hépatite alcoolique sévère | 2011-01-11 | due-trials |
Reported results | 2006-004720-37 | Effect of Voluven on postoperative morbidity after gynaecological surgery | 2009-04-03 | due-trials |
Reported results | 2006-004066-14 | Etude des effets de l'enoximone sur la sensibilité du chémorécepteur. | 2007-09-30 | due-trials |
Reported results | 2006-003133-33 | Etude des effets d’un antagoniste non spécifique de l’endothéline (le bosentan) sur l’activité orthosympathique et le chémoréflexe. | 2011-12-30 | due-trials |
Reported results | 2006-001945-32 | Introduction of everolimus is associated with a reduction in the dosage of calcineurine-inhibitors in patients with a pulmonary graft who suffer from a notable chronic renal insuffisance. | 2008-02-29 | due-trials |
Not reported | 2006-001765-42 | A prospective and randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with new-onset diabetes mellitus after renal transplantation (REVERSE study... | 2015-04-17 | due-trials |
Reported results Terminated | 2005-004288-47 | Etude des effets d'un antagoniste calcique(la barnidipine) sur la sensibilité des chémorécepteurs et l'activité orthosympathique. | 2006-09-30 | due-trials |